Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved

• Published in: Autoimmunity (Chur, Switzerland) Vol. 51; no. 5; pp. 258 - 264
• Main Authors: Lee, Briton, Holt, Edward W., Wong, Robert J., Sewell, Justin L., Somsouk, Ma, Khalili, Mandana, Maher, Jacquelyn J., Tana, Michele M.
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 04-07-2018; Taylor & Francis Group
• Subjects: Adult; Aged; Aged, 80 and over; Autoimmune liver disease; Ethnicity - statistics & numerical data; Female; Health Status Disparities; Hepatitis, Autoimmune - epidemiology; Hepatitis, Autoimmune - immunology; Humans; liver; liver fibrosis; Male; Middle Aged; outcomes research; Prevalence; race/ethnicity; Racial Groups - statistics & numerical data; Retrospective Studies; Risk Factors; San Francisco - epidemiology; Vulnerable Populations - statistics & numerical data; Young Adult; San Francisco; Autoimmune liver disease; liver fibrosis; outcomes research; liver; race/ethnicity
• ISSN: 0891-6934; 1607-842X
• DOI: 10.1080/08916934.2018.1482884

Although autoimmune hepatitis (AIH) is more common in women and affects people of all races/ethnicities, there is currently limited information regarding the relationship between race/ethnicity and AIH, especially in the context of underserved populations. We aim to evaluate the relationship between race/ethnicity and AIH and better characterize its clinical features among different racial groups. We conducted a 15-year retrospective analysis, from January 2002 to June 2017, of patients seen at Zuckerberg San Francisco General Hospital (ZSFG). Sixty-three AIH patients and 2049 non-AIH controls were eligible for the study. The main predictor of interest was race/ethnicity, and the main outcome of interest was AIH diagnosis; other secondary measures recorded include clinical features such as ALT, bilirubin, and biopsy fibrosis at presentation. In a multivariable model adjusting for age and sex, we found that black (OR 9.6, 95% CI 1.8-178), Latino (OR 25.0, 95% CI 5.3-448), and Asian/Pacific Islander (API) (OR 10.8, 95% CI 2.2-196) race/ethnicity were associated with increased odds of an AIH diagnosis compared to the white reference group. Among people of colour with AIH, there were no significant differences in baseline ALT (p = .45), total bilirubin at presentation (p = .06), fibrosis at presentation (p = .74), and hospitalization (p = .27). Race/ethnicity is an independent risk factor for AIH. The clinical features of AIH did not differ significantly among black, Latino, and API patients.